While demand remains exceptionally high, Lilly's expanded capacity for Mounjaro and Zepbound (both GLP-1 drugs indirectly supported by this investment) could challenge Novo Nordisk's market share, especially if Novo Nordisk experiences its own supply constraints or if Lilly achieves superior efficiency and availability
The timing between when youre using GLP-1s and when you get pregnant needs to be really thoughtful. In the event a woman becomes pregnant while taking a GLP-1, any risks to the fetus remain unclear, according to Finkle
The frequency depends on your wellness goals
Weight loss medications carry risks including nausea, vomiting, pancreatitis, and thyroid C-cell tumors (observed in rodents)
In essence, it steals their spot in the metabolic queue
Reprogrammed stem cells implanted into patient with Parkinsons disease